1BM6

SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR, NMR, 20 STRUCTURES

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	1H				6.8		310
2	15N HSQC				6.8		310
3	1H				6.8		310
4	13C				6.8		310
5	HMQC				6.8		310
6	3D CBCA(CO)NH				6.8		310
7	3D HNCA				6.8		310
8	3D HNHA				6.8		310
9	3D HCCH-TOCSY				6.8		310
10	13C-FILTERED COSY				6.8		310
11	13C				6.8		310
12	15N FILTERED NOESY				6.8		310
13	3D 15N EDITED NOESY				6.8		310
14	3D 13C EDITED NOESY				6.8		310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX600	600

NMR Refinement
Method	Details	Software
simulated annealing	REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.	X-PLOR

NMR Ensemble Information
Conformer Selection Criteria	LEAST RESTRAINT VIOLATION, ENERGY MINIMIZATION
Conformers Calculated Total Number	50
Conformers Submitted Total Number	20

Additional NMR Experimental Information
Details	THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY USING 13C,15N STROMELYSIN CATALYTIC DOMAIN.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	X-PLOR	3.1	BRUNGER
2	structure solution	BRUKER XWINNMR	XWINNMR
3	structure solution	MSI NMRCOMPASS	NMRCOMPASS
4	structure solution	Felix
5	structure solution	NMRPipe

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.